Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions

File
Ghosh, M., Andrei, S., Damron, D., Bosma, K., Zhong, L., Dunn, J., Ricciardi, V., Burkett, J., Hatzopoulos, A., & Gannon, M. (2022). Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions. Physiological Reports. https://doi.org/10.14814/phy2.15212
Ghosh, Monica, Spencer Andrei, Derek Damron, Karin Bosma, Lin Zhong, Jennifer Dunn, Valerie Ricciardi, Juliann Burkett, Antonis Hatzopoulos, and Maureen Gannon. 2022. “Pharmacological Modulation of Prostaglandin E2 (PGE2) EP Receptors Improves Cardiomyocyte Function under Hyperglycemic Conditions”. Physiological Reports. https://doi.org/10.14814/phy2.15212.
Ghosh, M., S. Andrei, D. Damron, K. Bosma, L. Zhong, J. Dunn, V. Ricciardi, J. Burkett, A. Hatzopoulos, and M. Gannon. Pharmacological Modulation of Prostaglandin E2 (PGE2) EP Receptors Improves Cardiomyocyte Function under Hyperglycemic Conditions. Physiological Reports, 10 Apr. 2022, doi:10.14814/phy2.15212.